A research team at Cincinnati Children’s Hospital Medical Center has received a $626,000 grant to test saracatinib (AZD0530), an experimental drug, as a new potential treatment for cystic fibrosis (CF). The grant will support further preclinical evaluation of this new
Computational Analyses Lead to Grant for Potential Cystic Fibrosis Treatment
